[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @pick1998_2 Nick zheng Nick zheng posts on X about $vstm, aav, $srpt, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::425402956/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +202% - X Months XXXXXX +382% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::425402956/posts_active)  - X Week X +29% - X Month XX +50% - X Months XX +600% - X Year XX no change ### Followers: XXXXX [#](/creator/twitter::425402956/followers)  - X Week XXXXX +0.42% - X Month XXXXX +1.50% - X Months XXXXX +4.50% - X Year XXXXX +6.10% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::425402956/influencer_rank)  ### Social Influence [#](/creator/twitter::425402956/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$vstm](/topic/$vstm) 5.56%, [aav](/topic/aav) 2.78%, [$srpt](/topic/$srpt) 2.78%, [discount](/topic/discount) 2.78%, [$mreo](/topic/$mreo) 2.78%, [drugs](/topic/drugs) 2.78%, [stocks](/topic/stocks) 2.78%, [$urgn](/topic/$urgn) 2.78%, [c3](/topic/c3) 2.78%, [$apls](/topic/$apls) XXXX% **Top accounts mentioned or mentioned by** [@fireworkstrades](/creator/undefined) [@nolastevedore](/creator/undefined) [@achillestxcom](/creator/undefined) [@melvinriskmgmt](/creator/undefined) [@lramseu](/creator/undefined) [@ej23ny](/creator/undefined) [@buffalo51766917](/creator/undefined) [@stocksdd](/creator/undefined) [@ravi1982nl](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) ### Top Social Posts [#](/creator/twitter::425402956/posts) --- Top posts by engagements in the last XX hours "$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945600798219800844) 2025-07-16 21:45:52 UTC 6922 followers, 7126 engagements "$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1944774197437448259) 2025-07-14 15:01:15 UTC 6921 followers, 3831 engagements "$VSTM $URGN keep adding these two cheap biotech stocks with unique approved drugs for specific cancers"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1940816161412886577) 2025-07-03 16:53:26 UTC 6922 followers, 1721 engagements "$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1946231638557618231) 2025-07-18 15:32:36 UTC 6910 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Nick zheng posts on X about $vstm, aav, $srpt, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXX% finance XXXX%
Social topic influence $vstm 5.56%, aav 2.78%, $srpt 2.78%, discount 2.78%, $mreo 2.78%, drugs 2.78%, stocks 2.78%, $urgn 2.78%, c3 2.78%, $apls XXXX%
Top accounts mentioned or mentioned by @fireworkstrades @nolastevedore @achillestxcom @melvinriskmgmt @lramseu @ej23ny @buffalo51766917 @stocksdd @ravi1982nl
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Apellis Pharmaceuticals, Inc. Common Stock (APLS)
Top posts by engagements in the last XX hours
"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30" @pick1998_2 on X 2025-07-16 21:45:52 UTC 6922 followers, 7126 engagements
"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year" @pick1998_2 on X 2025-07-14 15:01:15 UTC 6921 followers, 3831 engagements
"$VSTM $URGN keep adding these two cheap biotech stocks with unique approved drugs for specific cancers" @pick1998_2 on X 2025-07-03 16:53:26 UTC 6922 followers, 1721 engagements
"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability" @pick1998_2 on X 2025-07-18 15:32:36 UTC 6910 followers, XXX engagements
/creator/twitter::pick1998_2